Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger and BTB domain containing 21 (ZBTB21) is a protein-coding gene that encodes a member of the ZBTB family of transcription factors, characterized by the presence of C2H2-type zinc fingers and a BTB/POZ domain. The protein acts as a transcriptional repressor by binding to DNA and recruiting corepressors, which mediate gene silencing through chromatin remodeling and methyl-CpG binding. ZBTB21 is localized in the cytosol and nucleoplasm. Mutations in ZBTB21 are linked to neurodevelopmental disorders such as Coffin-Siris Syndrome 1 and Intellectual Developmental Disorder, Autosomal Dominant 7. Its molecular function is inferred mainly from homology with other ZBTB proteins which control cell differentiation, proliferation, and apoptosis via regulation of gene expression[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger and BTB domain containing 21 (ZBTB21).